These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 9458081

  • 1. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 3. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS, Rao CV, Seibert K.
    Cancer Res; 1996 Oct 15; 56(20):4566-9. PubMed ID: 8840961
    [Abstract] [Full Text] [Related]

  • 5. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV.
    Cancer Res; 2005 Sep 01; 65(17):8022-7. PubMed ID: 16140976
    [Abstract] [Full Text] [Related]

  • 6. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS.
    Cancer Res; 2001 May 01; 61(9):3647-52. PubMed ID: 11325834
    [Abstract] [Full Text] [Related]

  • 7. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV, Hirose Y, Indranie C, Reddy BS.
    Cancer Res; 2001 Mar 01; 61(5):1927-33. PubMed ID: 11280748
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of experimental colon cancer by genistein.
    Rao CV, Wang CX, Simi B, Lubet R, Kelloff G, Steele V, Reddy BS.
    Cancer Res; 1997 Sep 01; 57(17):3717-22. PubMed ID: 9288778
    [Abstract] [Full Text] [Related]

  • 9. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV.
    Cancer Res; 2006 Apr 15; 66(8):4542-6. PubMed ID: 16618783
    [Abstract] [Full Text] [Related]

  • 10. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
    Singh J, Hamid R, Reddy BS.
    Cancer Res; 1997 Aug 15; 57(16):3465-70. PubMed ID: 9270014
    [Abstract] [Full Text] [Related]

  • 11. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE.
    Anticancer Res; 2001 Aug 15; 21(5):3425-32. PubMed ID: 11848504
    [Abstract] [Full Text] [Related]

  • 12. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats.
    Shih CK, Chiang W, Kuo ML.
    Food Chem Toxicol; 2004 Aug 15; 42(8):1339-47. PubMed ID: 15207385
    [Abstract] [Full Text] [Related]

  • 13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
    Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ.
    Mol Carcinog; 1999 Aug 15; 25(4):231-40. PubMed ID: 10449029
    [Abstract] [Full Text] [Related]

  • 14. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
    Rao CV, Rivenson A, Katiwalla M, Kelloff GJ, Reddy BS.
    Cancer Res; 1993 Jun 01; 53(11):2502-6. PubMed ID: 8495412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
    Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P, el-Bayoumy K.
    Cancer Res; 1992 Oct 15; 52(20):5635-40. PubMed ID: 1394188
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
    Kawamori T, Uchiya N, Kitamura T, Ohuchida S, Yamamoto H, Maruyama T, Sugimura T, Wakabayashi K.
    Anticancer Res; 2001 Oct 15; 21(6A):3865-9. PubMed ID: 11911260
    [Abstract] [Full Text] [Related]

  • 18. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS.
    Cancer Res; 1997 Apr 01; 57(7):1301-5. PubMed ID: 9102217
    [Abstract] [Full Text] [Related]

  • 19. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
    Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS.
    Cancer Res; 1995 Jun 01; 55(11):2310-5. PubMed ID: 7757981
    [Abstract] [Full Text] [Related]

  • 20. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.
    Rao CV, Rivenson A, Simi B, Reddy BS.
    Cancer Res; 1995 Jan 15; 55(2):259-66. PubMed ID: 7812955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.